|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Unité de Biochimie Structurale (CNRS-URA 2185), Institut Pasteur, 75724 Paris, France
2 Plate-forme de Cristallogenèse et Diffraction des Rayons-X, Institut Pasteur, 75724 Paris, France
3 Plate-forme de Production de Protéines Recombinantes Institut Pasteur, 75724 Paris, France
4 Synchrotron Soleil, L'Orme de Merisiers, 91192 Gif sur Yvette, France
5 Unité de Génétique Moléculaire Bactérienne, Institut Pasteur, 75724 Paris, France
(RECEIVED May 3, 2007; FINAL REVISION June 2, 2007; ACCEPTED June 5, 2007)
| Abstract |
|---|
|
|
|---|
/
core and the AdoMet-binding site are very well conserved within the family. However, the amino acid positions defining the binding site for the acceptor substrate display a higher variability, suggestive of distinct acceptor substrate specificities. The ML2640c crystal structures offer the first structural glimpses at this important family of mycobacterial proteins and lend strong support to their functional assignment as AdoMet-dependent methyltransferases. Keywords: S-adenosylmethionine-dependent methyltransferase; Mycobacterium leprae ; X-ray crystallography; function discovery
| Introduction |
|---|
|
|
|---|
40%) lacks functional annotation. A comparative analysis of different mycobacterial genomes, including those of the important human pathogens Mycobacterium tuberculosis (Cole et al. 1998) and M. leprae (Cole et al. 2001), led to the identification of several conserved families of hypothetical proteins that are largely restricted to mycobacteria or actinomycetes. The M. leprae protein ML2640c belongs to one of these families, which is highly represented in some mycobacterial genomes. Thus, there are as many as 22 ML2640c-like genes in M. avium, 17 in M. tuberculosis, and 13 in M. ulcerans. Some of these proteins (classified into the Cluster of Orthologous Groups [COG] named COG3315; Tatusov et al. 2001) are annotated as S-adenosylmethionine (AdoMet)-dependent methyltransferases (MTases) involved in polyketide biosynthesis, because they share a conserved motif found at the N terminus of polyketide synthesis O-MTases (PFAM entry Omt_N); (Bateman et al. 2004). However, direct biochemical or structural data validating this functional assignment is missing for the entire ML2640c-like mycobacterial family. As part of our Structural Genomics initiative that was focused on conserved hypothetical proteins of mycobacteria (Alzari et al. 2006; Fogg et al. 2006; Shepard et al. 2007), we have determined the crystal structure of ML2640c to obtain novel insights into the functional role of this protein family. The structure reveals a typical MTase core domain, which is highly conserved in the entire family and binds AdoMet in a similar way as observed in other known class I MTase structures. The acceptor substrate-binding site is occluded from the solvent and displays a largely apolar surface, suggesting that ML2640c-like enzymes might methylate lipid-like molecules. The higher variability of the amino acid residues defining this binding site in the ML2640c-like family also indicates that different members of the family could target distinct acceptor substrates. The crystal structures of ML2640c further validate the functional assignment of this protein family as AdoMet-dependent methyltransferases and provide useful hints on the structural basis of substrate binding and specificity.
| Results and Discussion |
|---|
|
|
|---|
|
/
C-terminal domain made up of a central
-sheet flanked by
-helices (Fig. 1). The N-terminal helical domain is formed by the antiparallel association of three helices (
1–
3) packed at a right angle against a helical hairpin formed by
4 and the first part of the long
5. This domain presents a concave surface that is covered by an insertion from the C-terminal domain including helix
10 (see below). The
/
C-terminal domain contains a central seven-stranded
-sheet, with strand
7 antiparallel to the other six strands, and three helices on each side (Fig. 1B). This topology corresponds to that observed for the highly conserved structural fold of AdoMet-dependent methyltransferases (Martin and McMillan 2002; Schubert et al. 2003). The major deviation from this fold in the C-terminal domain is a 30-residue insertion between
5 and
11 (222–256, Fig. 1B), which includes helix
10 and folds over the N-terminal helical domain. This region displays large temperature factors in the tetragonal structure (Fig. 1A) and is disordered in the hexagonal crystal form, suggesting that it could serve as a flap for ligand binding to the acceptor substrate-binding site.
|
-sheet and flanking helices, matches the equivalent region from several eukaryotic and bacterial methyltransferases (Table 2). All methods, however, retrieved the same closest structural neighbor of ML2640c, namely the protein phosphatase methyltransferase 1 (PPM1) from yeast (PDB code 1RJD
[PDB]
) (Leulliot et al. 2004). On the other hand, no significant hits were obtained with any of the above programs when using only the N-terminal domain of ML2640c (helices
1–
5) as a search probe, suggesting that the helical arrangement of this region in ML2640c has not been previously observed in other protein structures.
|
|
1 and the first part of the AdoMet-dependent MTase fold (from strands
1 to
5, see Fig. 1B) are highly conserved, whereas a more important variability is observed for the rest of the N-terminal helical domain and the second half of the AdoMet-dependent MTase fold. When the invariant residues were mapped into the 3D structure, all amino acid residues defining the AdoMet-binding pocket as seen in the PPM1 structure were observed to be strictly or largely conserved (Fig. 3). This conservation pattern, which probably reflects functional rather than structural constraints, is a strong indicator that most ML2640c-like proteins share the capability of binding the methyl donor substrate AdoMet.
|
H°/
G° = 77.5%). The large value of the enthalpy term, the low K d value, and the 1:1 stoichiometry support a specific binding mechanism of the methyl donor substrate to the putative ML2640c active site.
|
/
C-terminal domain were closely similar to those observed in other MTases such as PPM1 (Fig. 4C). The amino acid moiety of AdoMet was disordered in the ML2640c complex, probably because the protein complex failed to reach a final stable state in the crystalline state. Although our attempts to co-crystallize the protein–ligand complex were unsuccessful, the superposition of the ML2640c and PPM1 structures shows that the conformation of the amino acid moiety, as seen in the PPM1 structure, can be accommodated with no steric clashes within the ML2640c binding pocket (Fig. 4C).
No significant structural differences are observed between the apo form of ML2640c and the AdoMet bound complex (root mean square deviation is 0.4 Å for all C
positions). The ligand is bound within a deep pocket at the center of the protein, with contributions from the C-terminal ends of strands
1 to
4 and the N-terminal helix
1. In ML2640c, AdoMet binding follows the same mode as class I methyltransferases (Martin and McMillan 2002). The adenine base of AdoMet is stabilized by van der Waals interactions with Leu162, Leu188 and the aliphatic portion of Gln133, and by hydrogen-bonding interactions of the N6 and N1 positions with the Asp161 side chain and the Leu162 main-chain NH, respectively. The ribose moiety is close to protein residues Ala110 and Gly112, which are strictly conserved in ML2640c-like proteins (Supplemental Fig. 1) and correspond to the conserved motif GxG of class I MTases (Martin and McMillan 2002). The carboxylate oxygens of Asp132 are hydrogen bonded to the ribose O2 and O3 hydroxyls (Fig. 4B), and the side-chain residues Arg25, Arg87, and Glu186 could make electrostatic interactions with the charged tail of the AdoMet residue.
The structure of the ML2640c–AdoMet complex confirmed the prediction from sequence analysis (Fig. 3), since all residues in contact with AdoMet are highly conserved in the family (Supplemental Fig. 1). The motif VGxTAxxVAxxRA in helix
1 (positions 14–26) includes the contact residues Gly15, Ala18, Val21, and Arg25 and is conserved in the family (except for Val21, replaced by Ile in some sequences), even though helix
1 seems to make mostly nonspecific contacts with the ligand. Other invariant residues interacting with the methyl-donor substrate in the ML2640c complex involve Ala110 and Gly112 between
1 and
6, Glu130 and Asp132 at the C terminus of
2, Asp161–Leu162–Arg163 between
3 and
8, and Glu186–Gly187–Leu188 between
4 and
9. This high conservation pattern, together with the binding and structural studies of the ML2640c–AdoMet complex, strongly validates the functional assignment of the ML2640c-like family of mycobacterial homologs as AdoMet-dependent MTases.
The architecture of the AdoMet-binding site is remarkably similar in ML2640c and PPM1. In the two proteins, the entrance to the substrate-binding site is partially occluded by the N terminus of helix
1 and by loops
2–
7 and
3–
8. However, the solvent-exposed surface of bound substrate is higher in the ML2640c complex (67 Å2) than in the PPM1 complex (8 Å2), as calculated with the program AreaIMol from the CCP4 package (Collaborative Computational Project, Number 4 1994). The difference is mostly due to the phenol group of PPM1 Tyr129 (replaced by Gln133 in ML2640c), which makes stacking interactions with the adenine base and occludes it from the solvent in PPM1. Although we cannot exclude the existence of a more open form of the apoprotein in solution, the crystal structure suggests that a relatively large conformational change would be necessary for AdoMet to enter (or for the reaction product to exit) the binding cavity. Indeed, such structural changes could explain the observed cracking of ML2640c crystals upon soaking with substrate. They could also involve the N-terminal segment of the protein (before
1), which is disordered in the two crystal forms of apo-ML2640c and might undergo a structural rearrangement upon AdoMet binding.
The binding site for the methyl acceptor substrate
The ML2640c structure clearly revealed the presence of two large pockets or cavities within the 3D structure (Fig. 5A). One of these pockets is occupied by the methyl donor substrate AdoMet, as seen in the crystal structure of the complex. The second cavity is connected to the AdoMet-binding pocket at the position of the transferable methyl group and should therefore represent the acceptor substrate-binding site. It is primarily defined by residues from helices
1 and
5, the C-terminal ends of strands
4 and
5, and the protein loop immediately preceding
7. Furthermore, flap residues 230–234 (helix
10) and 248–252 cover the site and isolate it from the solvent (Fig. 5A). Mobility of the flap (as seen in the hexagonal crystal form) connects the binding site to the bulk solvent, suggesting that the flap could serve as a gateway for substrate entry and product release.
|
The wide diversity in the biological roles of methylation is paralleled by the baffling number of methyltransferase enzymes that catalyze the methylation reaction. While a great majority of these enzymes use AdoMet as the methyl donor substrate, the binding site for the acceptor substrate is highly variable in AdoMet-dependent MTases (Martin and McMillan 2002). More than 120 members of this family (EC 2.1.1.X) have been identified, based on acceptor substrate specificity (small molecules, lipids, proteins, and nucleic acids) and the atom targeted for methylation (nitrogen, oxygen, carbon, and sulfur). Although we can only speculate on the putative nature of the ML2640c acceptor substrate, some insights can be gathered from a structural comparison of the acceptor substrate-binding site in other MTases. Depending on the nature of the substrate, the shape, size, and electrostatic properties of the binding site may vary widely. Thus, in MTases that transfer a methyl group to macromolecules such as DNA or proteins (Fig. 5B), the binding site is a rather shallow region of the molecular surface. In PPM1 (Fig. 5C), which methylates the C-terminal leucine in protein phosphatase 2A, the binding site is a relatively deep conical cavity (14 Å) that connects the catalytic center with the bulk solvent. On the other hand, MTases that use smaller soluble molecules as substrates may bind them in solvent-exposed grooves (one example is catechol-O-MTase; Fig. 5D) or in protein buried cavities (as in glycine MTase; Fig. 5E). Finally, lipids or similar hydrophobic acceptor substrates are expected to bind internal cavities of mostly apolar character, as observed for instance in mycolic acid cyclopropane synthase (Fig. 5F).
In ML2640c, the solvent inaccessibility of the putative acceptor substrate-binding site, its rather apolar character, and large internal volume (
400 Å3, similar to that of cyclopropane synthases [Huang et al. 2002], see Fig. 5A,F) suggest that the protein could methylate small or medium-sized lipid-like molecules. The large number of ML2640c-like paralogs in some mycobacterial genomes could thus reflect the participation of these enzymes at several stages in the biosynthesis of lipid-like metabolites. The structural data are also in agreement with the predicted functional assignment of the COG3315 family as MTases involved in polyketide (i.e., lipid-like) biosynthesis (Tatusov et al. 2001). Indeed, the ML2640c family of proteins appears to be largely restricted to bacteria in the order Actinomycetales, which are among the organisms known to produce a diversity of complex polyketides as secondary metabolites (Hopwood and Sherman 1990; Katz and Donadio 1993). However, it is puzzling that in no case is an ML2640c ortholog linked to a known gene cluster involved in polyketide or lipid biosynthesis in the sequenced mycobacterial genomes and this may suggest that other metabolites are the substrate. This is currently the subject of investigation.
| Materials and Methods |
|---|
|
|
|---|
cells was done in 50 µL and two transformants were screened for recombinant insert analysis. After sequencing, a streak of freshly transformed BL21(DE3)pLysS cells by pDEST-ML2640c was used to inoculate 500 mL of LB medium containing 100 µg/mL ampicillin and 25 µg/mL chloramphenicol. The culture was then grown for 3.5 h at 30°C and induced with 1 mM isopropopyl
-D-thiogalactoside (IPTG) at OD600 of 0.8–0.9. After 1.5 h of induced growth, cells were harvested by centrifugation, resuspended, and frozen in 50 mM Tris-HCl buffer containing 150 mM NaCl and 10 mM imidazole, pH 8.0. Cellular suspension was thawed and cells lyzed in the French press at 14,000 psi. After centrifugation, the supernatant was loaded on Ni-NTA resin (Qiagen) and the protein eluted by a linear gradient of imidazole. The purified protein, diluted in 50 mM Tris-HCl buffer containing 0.1 M NaCl and 1 mM
-mercaptoethanol, pH 8.0, at 0.5 mg/mL, was incubated with His6-tagged TEV protease at a protein-TEV ratio (w/w) of 1:7 for 6 h at 30°C. After centrifugation, the supernatant was loaded on Ni-NTA resin, as above. The flow-through containing the tag-free protein was collected, analyzed on SDS-PAGE, and concentrated for crystallization. After cleavage with TEV, ML2640c contains a single Met
Gly substitution at the N terminus. The selenomethionine-labeled protein was produced in BL21(DE3) Escherichia coli cells (Novagen) as described (Wingfield 2000) and purified as described above for the nonlabeled protein.
Crystallization
Crystallization screens at 18°C were carried out using a Cartesian Technology workstation. Sitting-drops were composed of 200 nL of native ML2640c protein (12 mg/mL) and 200 nL of mother liquor equilibrated against 150 µL of the well solution on Greiner plates. Two different crystal forms were obtained from drops containing either sodium citrate or ammonium sulfate as precipitant. After manual optimization, the best crystals were obtained in 1.6 M ammonium sulfate, 50 mM MgCl2, and 100 mM Na-Hepes, pH 7.5 (tetragonal space group P43212), and 0.8 M sodium citrate, 100 mM Bicine, pH 9.0 (hexagonal space group P65). Crystals of seleno-L-methionine-labeled protein were obtained in the tetragonal space group and used for structure determination by SAD methods. Hexagonal ML2640c crystals were also soaked with 5 mM AdoMet. For data collection, crystals were transferred to a cryoprotectant solution containing the mother liquor +25% (v/v) of glycerol. All diffraction data sets were collected at the ESRF (Grenoble) using beamlines ID14.4 (SeMet-labeled protein) and ID29 (all other data sets).
Structure determination and refinement
The structure was determined using single-wavelength anomalous diffraction (SAD) data from a tetragonal crystal of SeMet-labeled ML2640c, measured at the K edge of selenium (Table 1). The substructure of the Se atoms was solved by direct methods (Weeks and Miller 1999) locating 16 sites, which were thereafter refined using SHARP (de La Fortelle and Bricogne 1997), allowing the identification of two additional minor sites. The electron density maps calculated with the solvent-flipped (Abrahams and Leslie 1996) SAD phases to 3.2 Å resolution allowed tracing the entire polypeptide chain for the two molecules in the asymmetric unit, except for the first seven (first molecule) or 12 (second molecule) N-terminal residues.
Model optimization was carried out by alternating crystallographic refinement cycles with the program REFMAC (Murshudov et al. 1999) and manual rebuilding with the programs O (Jones et al. 1991) and COOT (Emsley and Cowtan 2004) against a 2.8 Å resolution data set collected for the unlabeled protein. The refined model was subsequently used to solve the structure of the hexagonal crystal form, which contains only one molecule in the asymmetric unit, using molecular replacement methods (Navaza 1994). The crystallographic refinements of the protein alone to 1.7 Å resolution and its complex with AdoMet to 1.8 Å resolution were carried out as above, except that water molecules were now introduced in the model. In the hexagonal crystal form, two protein loops (residues 58–69 and 241–250) are disordered and were excluded from the final models. The parameters for the final refinement cycles are shown in Table 1.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) was performed using a VP-ITC (MicroCal). ML2640c was dialyzed into Hepes 0.1 M pH 7.0 buffer and AdoMet (Sigma) was resuspended into the same batch of the same buffer. Titration was performed by injecting 23 consecutive aliquots (10 µL) of AdoMet (100 µM) into the ITC cell containing ML2640c (3 µM) at 25°C. The heat of dilution of AdoMet was determined by performing the same experiment with the ITC cell containing buffer alone. The raw calorimetric data corrected for the heat of dilution was analyzed using the ORIGINTM software provided by the manufacturer. The molar binding stoichiometry (N), association constant (K a; K d = 1/K a), and molar binding enthalpy (
H°) were determined by fitting the binding isotherm to a model with one set of sites. The binding entropy change (T
S) was calculated (
G =
H – T
S).
Bioinformatics tools and procedures
Sequence database searches were performed with BLAST at NCBI (Altschul et al. 1997). Fold searches and comparisons were done with DALI (Holm and Sander 1998), SSM (Krissinel and Henrick 2004), and VAST at NCBI (Gibrat et al. 1996). The APBS program, which solves the Poisson-Boltzmann equation in vacuum medium (Baker et al. 2001), was used for electrostatic calculations. Figures were prepared with PyMOL (http://pymol.sourceforge.net).
Protein Data Bank deposition
The atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 2CKD (tetragonal crystal form), 2UYO (hexagonal crystal form), and 2UYQ (ML2640c–AdoMet complex, hexagonal crystal form).
| Footnotes |
|---|
Supplemental material: see www.proteinscience.org
Reprint requests to: Pedro M. Alzari, Unité de Biochimie Structurale, Institut Pasteur, 25 rue du Dr. Roux, F-75724 Paris Cedex 15, France; e-mail: alzari{at}pasteur.fr; fax: 33-1-45688604.
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.072982707.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D.J. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25: 3389–3402.
Alzari, P.M., Berglund, H., Berrow, N.S., Blagova, E., Busso, D., Cambillau, C., Campanacci, V., Christodoulou, E., Eiler, S., Fogg, M.J., et al. 2006. Implementation of semi-automated cloning and prokaryotic expression screening: The impact of SPINE. Acta Crystallogr. D Biol. Crystallogr. 62: 1103–1113.[CrossRef][Medline]
Baker, N.A., Sept, D., Joseph, S., Holst, M.J., and McCammon, J.A. 2001. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98: 10037–10041.
Bateman, A., Coin, L., Durbin, R., Finn, R.D., Hollich, V., Griffiths-Jones, S., Khanna, A., Marshall, M., Moxon, S., Sonnhammer, E.L., et al. 2004. The Pfam protein families database. Nucleic Acids Res. 32: D138–D141.
Bonifacio, M.J., Archer, M., Rodrigues, M.L., Matias, P.M., Learmonth, D.A., Carrondo, M.A., and Soares-da-Silva, P. 2002. Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application. Mol. Pharmacol. 62: 795–805.
Cole, S.T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S.V., Eiglmeier, K., Gas, S., Barry III, C.E., et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537–544.[CrossRef][Medline]
Cole, S.T., Eiglmeier, K., Parkhill, J., James, K.D., Thomson, N.R., Wheeler, P.R., Honore, N., Garnier, T., Churcher, C., Harris, D., et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409: 1007–1011.[CrossRef][Medline]
Collaborative Computational Project, Number 4 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760–763.[CrossRef][Medline]
de La Fortelle, E. and Bricogne, G. 1997. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276: 472–494.
Djordjevic, S. and Stock, A.M. 1998. Chemotaxis receptor recognition by protein methyltransferase CheR. Nat. Struct. Biol. 5: 446–450.[CrossRef][Medline]
Emsley, P. and Cowtan, K. 2004. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126–2132.[CrossRef][Medline]
Fogg, M.J., Alzari, P.M., Bahar, M., Bertini, I., Betton, J.M., Burmeister, W.P., Cambillau, C., Canard, B., Carrondo, M., Coll, M., et al. 2006. Application of the use of high-throughput technologies to the determination of protein structures of bacterial and viral pathogens. Acta Crystallogr. D Biol. Crystallogr. 62: 1196–1207.[CrossRef][Medline]
Gibrat, J.F., Madej, T., and Bryant, S.H. 1996. Surprising similarities in structure comparison. Curr. Opin. Struct. Biol. 6: 377–385.[CrossRef][Medline]
Holm, L. and Sander, C. 1998. Touring protein fold space with DALI/FSSP. Nucleic Acids Res. 26: 316–319.
Hopwood, D.A. and Sherman, D.H. 1990. Molecular genetics of polyketides and its comparison to fatty acid biosynthesis. Annu. Rev. Genet. 24: 37–66.[CrossRef][Medline]
Huang, C.C., Smith, C.V., Glickman, M.S., Jacobs, W.R., and Sacchettini, J.C. 2002. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis . J. Biol. Chem. 277: 11559–11569.
Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110–119.[CrossRef]
Katz, L. and Donadio, S. 1993. Polyketide synthesis: Prospects for hybrid antibiotics. Annu. Rev. Microbiol. 47: 875–912.[CrossRef][Medline]
Krissinel, E. and Henrick, K. 2004. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60: 2256–2268.[CrossRef][Medline]
Leulliot, N., Quevillon-Cheruel, S., Sorel, I., de La Sierra-Gallay, I.L., Collinet, B., Graille, M., Blondeau, K., Bettache, N., Poupon, A., Janin, J., et al. 2004. Structure of protein phosphatase methyltransferase 1 (PPM1), a leucine carboxyl methyltransferase involved in the regulation of protein phosphatase 2A activity. J. Biol. Chem. 279: 8351–8358.
Martin, J.L. and McMillan, F.M. 2002. SAM (dependent) I AM: The S-adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 12: 783–793.[CrossRef][Medline]
Murshudov, G.N., Vagin, A.A., Lebedev, A., Wilson, K.S., and Dodson, E.J. 1999. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D Biol. Crystallogr. 55: 247–255.[CrossRef][Medline]
Navaza, J. 1994. AMoRe: An automated package for molecular replacement. Acta Crystallogr. A 50: 157–163.[CrossRef]
Schubert, H.L., Blumenthal, R.M., and Cheng, X. 2003. Many paths to methyltransfer: A chronicle of convergence. Trends Biochem. Sci. 28: 329–335.[CrossRef][Medline]
Shepard, W., Haouz, A., Graña, M., Buschiazzo, A., Betton, J.M., Cole, S.T., and Alzari, P.M. 2007. The crystal structure of Rv0813c from Mycobacterium tuberculosis reveals a new family of fatty acid binding protein-like proteins in bacteria. J. Bacteriol. 189: 1899–1904.
Takata, Y., Huang, Y., Komoto, J., Yamada, T., Konishi, K., Ogawa, H., Gomi, T., Fujioka, M., and Takusagawa, F. 2003. Catalytic mechanism of glycine N-methyltransferase. Biochemistry 42: 8394–8402.[CrossRef][Medline]
Tatusov, R.L., Natale, D.A., Garkavtsev, I.V., Tatusova, T.A., Shankavaram, U.T., Rao, B.S., Kiryutin, B., Galperin, M.Y., Fedorova, N.D., and Koonin, E.V. 2001. The COG database: New developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 29: 22–28.
Weeks, C.M. and Miller, R. 1999. The design and implementation of SnB v2.0. J. Appl. Crystallogr. 32: 120–124.[CrossRef]
Wingfield, P. 2000. Production of recombinant proteins. In Current protocols in protein science (eds. J. Coligan et al.), pp. 5.3.9–14. Wiley, New York.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |